SG Americas Securities’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9M Buy
66,000
+50,410
+323% +$13.4M 0.02% 467
2026
Q1
$1.71M Sell
15,590
-31,130
-67% -$4.43M ﹤0.01% 1467
2025
Q4
$7.77M Buy
46,720
+26,089
+126% +$4.36M 0.01% 888
2025
Q3
$4.04M Buy
+20,631
New +$3.39M 0.01% 595
2025
Q2
Sell
-2,046
Closed -$122K 3699
2025
Q1
$122K Buy
2,046
+702
+52% +$64.9K ﹤0.01% 2897
2024
Q4
$178K Sell
1,344
-10,002
-88% -$939K ﹤0.01% 2262
2024
Q3
$594K Buy
+11,346
New +$533K ﹤0.01% 1533

Other funds holding ALAB

SG Americas Securities's ALAB Position: Q2 2026 in Review

SG Americas Securities increased its Astera Labs (ALAB) stake by 323% in Q2 2026, buying an estimated $13.4M and bringing the position to 66,000 shares worth $31.9M. The position accounts for 0.02% of the portfolio, ranked #467.

SG Americas Securities first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • SG Americas Securities held 66,000 shares of Astera Labs worth $31.9M as of Q2 2026.
  • SG Americas Securities bought 50,410 Astera Labs shares in Q2 2026, an estimated $13.4M.
  • Astera Labs made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #467 holding.
  • SG Americas Securities first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.